Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PT-141 is also notable as the only one of the three FDA-approved for women sold as Vyleesi for hypoactive sexual desire disorder in premenopausal women
The beams reach the layer of fatty tissue directly underneath the skin
PMID: 1704369
Lilly Investors
no direct PubMed-indexed studies have measured cortisol levels following Semax administration Nasal Administration: Local irritation possible but typically mild Long-term Data: Decades of Russian clinical experience suggest good safety profile Selank Safety Profile: (PMID: 25176261, PMID: 28280289) Excellent Tolerability: Very few reported adverse events No Dependence Risk: Does not produce tolerance or withdrawalmajor advantage No Sedation: Unlike benzodiazepines, does not cause drowsiness or cognitive impairment No Muscle Relaxation: Anxiolytic effects without physical sedation Immunomodulatory Effects: May affect immune function
US$ 21.22
US$ 28.62
US$ 25.27
US$ 25.53
